4.2 Article

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture

Sylvie Perreault et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)

Article Pharmacology & Pharmacy

Developments in post-marketing comparative effectiveness research

S. Schneeweiss

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Review Endocrinology & Metabolism

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

J. A. Cramer et al.

OSTEOPOROSIS INTERNATIONAL (2007)

Article Endocrinology & Metabolism

Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis

JT Harrington et al.

CALCIFIED TISSUE INTERNATIONAL (2004)

Article Endocrinology & Metabolism

Undertreatment with anti-osteoporotic drugs after hospitalization for fracture

MJM Panneman et al.

OSTEOPOROSIS INTERNATIONAL (2004)

Article Medicine, General & Internal

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture

SE Andrade et al.

ARCHIVES OF INTERNAL MEDICINE (2003)

Article Medicine, General & Internal

Effect of risedronate on the risk of hip fracture in elderly women

MR McClung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)